Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer
Clinical trial NCT04356430 · UNKNOWN
Trial details
- NCT number
- NCT04356430
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2021-03-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.